These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 25322519
1. Designer drugs. Patients may be using synthetic cannabinoids more than you think. Lisi DM. JEMS; 2014 Sep; 39(9):56-9. PubMed ID: 25322519 [Abstract] [Full Text] [Related]
7. The emerging threat of synthetic cannabinoids. Phillips J, Lim F, Hsu R. Nurs Manage; 2017 Mar 25; 48(3):22-30. PubMed ID: 28234762 [No Abstract] [Full Text] [Related]
8. Top 10 Facts You Need to Know About Synthetic Cannabinoids: Not So Nice Spice. Kemp AM, Clark MS, Dobbs T, Galli R, Sherman J, Cox R. Am J Med; 2016 Mar 25; 129(3):240-4.e1. PubMed ID: 26522795 [Abstract] [Full Text] [Related]
9. Synthetic cannabinoid and cathinone use among US soldiers. Berry-Cabán CS, Kleinschmidt PE, Rao DS, Jenkins J. US Army Med Dep J; 2012 Mar 25; ():19-24. PubMed ID: 23007932 [Abstract] [Full Text] [Related]
10. Toxicology and management of novel psychoactive drugs. Kersten BP, McLaughlin ME. J Pharm Pract; 2015 Feb 25; 28(1):50-65. PubMed ID: 25261428 [Abstract] [Full Text] [Related]
11. Synthetic cannabinoid intoxication: a case series and review. Harris CR, Brown A. J Emerg Med; 2013 Feb 25; 44(2):360-6. PubMed ID: 22989695 [Abstract] [Full Text] [Related]
12. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling. Liechti M. Swiss Med Wkly; 2015 Feb 25; 145():w14043. PubMed ID: 25588018 [Abstract] [Full Text] [Related]
13. Synthetic cannabinoid use in a nationally representative sample of US high school seniors. Palamar JJ, Acosta P. Drug Alcohol Depend; 2015 Apr 01; 149():194-202. PubMed ID: 25736618 [Abstract] [Full Text] [Related]
14. Atrial fibrillation following synthetic cannabinoid abuse. Efe TH, Felekoglu MA, Çimen T, Doğan M. Turk Kardiyol Dern Ars; 2017 Jun 01; 45(4):362-364. PubMed ID: 28595208 [Abstract] [Full Text] [Related]
15. Clinical and financial implications of emergency department visits for synthetic marijuana. Rowley E, Benson D, Tiffee A, Hockensmith A, Zeng H, Jones GN, Musso MW. Am J Emerg Med; 2017 Oct 01; 35(10):1506-1509. PubMed ID: 28457767 [Abstract] [Full Text] [Related]
16. Notes from the Field: Increase in Reported Adverse Health Effects Related to Synthetic Cannabinoid Use - United States, January-May 2015. Law R, Schier J, Martin C, Chang A, Wolkin A, Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep; 2015 Jun 12; 64(22):618-9. PubMed ID: 26068566 [Abstract] [Full Text] [Related]
17. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry. Shanks KG, Dahn T, Behonick G, Terrell A. J Anal Toxicol; 2012 Jul 12; 36(6):360-71. PubMed ID: 22586208 [Abstract] [Full Text] [Related]
18. Synthetic cannabinoids: the dangers of spicing it up. Salani DA, Zdanowicz MM. J Psychosoc Nurs Ment Health Serv; 2015 May 12; 53(5):36-43. PubMed ID: 25974923 [Abstract] [Full Text] [Related]
19. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project. Helander A, Bäckberg M, Hultén P, Al-Saffar Y, Beck O. Forensic Sci Int; 2014 Oct 12; 243():23-9. PubMed ID: 24726531 [Abstract] [Full Text] [Related]
20. Geographic distribution of synthetic cannabinoid exposures reported to Texas poison centers. Forrester MB, Haywood T. Am J Drug Alcohol Abuse; 2012 Nov 12; 38(6):603-8. PubMed ID: 22571605 [Abstract] [Full Text] [Related] Page: [Next] [New Search]